Log in to save to my catalogue

Rationale for MYC imaging and targeting in pancreatic cancer

Rationale for MYC imaging and targeting in pancreatic cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4112c8cee8034d229192aa4dd81dd3f3

Rationale for MYC imaging and targeting in pancreatic cancer

About this item

Full title

Rationale for MYC imaging and targeting in pancreatic cancer

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

EJNMMI Research, 2021-10, Vol.11 (1), p.104-104, Article 104

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

The incidence and lethality of pancreatic ductal adenocarcinoma (PDAC) will continue to increase in the next decade. For most patients, chemotherapeutic combination therapies remain the standard of care. The development and successful implementation of precision oncology in other gastrointestinal tumor entities point to opportunities also for PDAC....

Alternative Titles

Full title

Rationale for MYC imaging and targeting in pancreatic cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4112c8cee8034d229192aa4dd81dd3f3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4112c8cee8034d229192aa4dd81dd3f3

Other Identifiers

ISSN

2191-219X

E-ISSN

2191-219X

DOI

10.1186/s13550-021-00843-1

How to access this item